The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
Abstract
A subtype of aggressive human muscle-invasive bladder cancer expresses basal epithelial markers and is sensitive to EGFR inhibition in preclinical models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Comprehensive molecular characterization of urothelial bladder carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/za09-dk57 · Cited by 2,990
Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Douillard, J.-Y., Oliner, K. S., Siena, S., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305275 · Cited by 2,263 · cited 3×
“e 244 244 M1 ce m CIT BL MIBC 21 (25) 1 6 (76) 5 (24) 69.”
BackgroundEvolving gene/transcript definitions significantly alter the interpretation of GeneChip data
Dai, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni179 · Cited by 1,797
Choi, W., Porten, S., Kim, S., Willis, D., Plimack, E. R., Hoffman-Censits, J., Roth, B., Cheng, T., Tran, M., Lee, I.-L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.009 · Cited by 1,716
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Boyault, S., Rickman, D. S., de Reyniès, A., Balabaud, C., Rebouissou, S., Jeannot, E., Hérault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007) · Hepatology · doi:10.1002/hep.21467 · Cited by 1,258
Self-citationSadanandam, A., Lyssiotis, C. A., Homicsko, K., Collisson, E. A., Gibb, W. J., Wullschleger, S., Ostos, L. C. G., Lannon, W. A., Grotzinger, C., Del Rio, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3175 · Cited by 960
A Molecular Taxonomy for Urothelial Carcinoma
Sjödahl, G., Lauss, M., Lövgren, K., Chebil, G., Gudjonsson, S., Veerla, S., Patschan, O., Aine, M., Fernö, M., Ringnér, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0077-t · Cited by 944
Monti, S. (2005) · Blood · doi:10.1182/blood-2004-07-2947 · Cited by 820
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression
Chung, C. H., Parker, J. S., Karaca, G., Wu, J., Funkhouser, W. K., Moore, D., Butterfoss, D., Xiang, D., Zanation, A., Yin, X., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00112-6 · Cited by 678 · cited 1×
“A basal-like subgroup has also been identified in several other cancers (lung, head and neck, ovarian, and salivary cancers) (32).”
BackgroundChan, K. S., Espinosa, I., Chao, M., Wong, D., Ailles, L., Diehn, M., Gill, H., Presti, J., Chang, H. Y., van de Rijn, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906549106 · Cited by 660
Perrotte, P., Matsumoto, T., Inoue, K., Kuniyasu, H., Eve, B. Y., Hicklin, D. J., Radinsky, R., & Dinney, C. P. (1999) · PubMed · Cited by 647
Carey, L. A., Rugo, H. S., Marcom, P. K., Mayer, E. L., Esteva, F. J., Ma, C. X., Liu, M. C., Storniolo, A. M., Rimawi, M. F., Forero-Torres, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.5579 · Cited by 499
Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) Tumors
Billerey, C., Chopin, D., Aubriot-Lorton, M.-H., Ricol, D., Gil Diez de Medina, S., Van Rhijn, B., Bralet, M.-P., Lefrere-Belda, M.-A., Lahaye, J.-B., Abbou, C. C., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64665-2 · Cited by 498
Self-citationHautmann, R. E., de Petriconi, R. C., Pfeiffer, C., & Volkmer, B. G. (2012) · European Urology · doi:10.1016/j.eururo.2012.02.028 · Cited by 417
Kim, W.-J., Kim, E.-J., Kim, S.-K., Kim, Y.-J., Ha, Y.-S., Jeong, P., Kim, M.-J., Yun, S.-J., Lee, K., Moon, S.-K., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-3 · Cited by 398
Basal Breast Cancer: A Complex and Deadly Molecular Subtype
Bertucci, F., Finetti, P., & Birnbaum, D. (2012) · Current Molecular Medicine · doi:10.2174/156652412798376134 · Cited by 394
Bladder Cancer Outcome and Subtype Classification by Gene Expression
Blaveri, E., Simko, J. P., Korkola, J. E., Brewer, J. L., Baehner, F., Mehta, K., DeVries, S., Koppie, T., Pejavar, S., Carroll, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2409 · Cited by 337
Huang, Y., de Reyniès, A., de Leval, L., Ghazi, B., Martin-Garcia, N., Travert, M., Bosq, J., Brière, J., Petit, B., Thomas, E., et al. (2010) · Blood · doi:10.1182/blood-2009-05-221275 · Cited by 313
Self-citationLindgren, D., Frigyesi, A., Gudjonsson, S., Sjödahl, G., Hallden, C., Chebil, G., Veerla, S., Ryden, T., Månsson, W., Liedberg, F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4213 · Cited by 310
Regional copy number–independent deregulation of transcription in cancer
Stransky, N., Vallot, C., Reyal, F., Bernard-Pierrot, I., de Medina, S. G. D., Segraves, R., de Rycke, Y., Elvin, P., Cassidy, A., Spraggon, C., et al. (2006) · Nature Genetics · doi:10.1038/ng1923 · Cited by 250
Self-citationRiester, M., Taylor, J. M., Feifer, A., Koppie, T., Rosenberg, J. E., Downey, R. J., Bochner, B. H., & Michor, F. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2271 · Cited by 232
Selecting Differentially Expressed Genes from Microarray Experiments
Pepe, M. S., Longton, G., Anderson, G. L., & Schummer, M. (2003) · Biometrics · doi:10.1111/1541-0420.00016 · Cited by 207
Dyrskjøt, L., Zieger, K., Real, F. X., Malats, N., Carrato, A., Hurst, C., Kotwal, S., Knowles, M., Malmström, P.-U., de la Torre, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2940 · Cited by 206
Self-citationNormal and neoplastic urothelial stem cells: getting to the root of the problem
Ho, P. L., Kurtova, A., & Chan, K. S. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.142 · Cited by 184
Freeman, M. R., Yoo, J. J., Raab, G., Soker, S., Adam, R. M., Schneck, F. X., Renshaw, A. A., Klagsbrun, M., & Atala, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119230 · Cited by 170
Sternberg, C. N., Bellmunt, J., Sonpavde, G., Siefker-Radtke, A. O., Stadler, W. M., Bajorin, D. F., Dreicer, R., George, D. J., Milowsky, M. I., Theodorescu, D., et al. (2013) · European Urology · doi:10.1016/j.eururo.2012.08.010 · Cited by 170
Differentiation of a Highly Tumorigenic Basal Cell Compartment in Urothelial Carcinoma
He, X., Marchionni, L., Hansel, D. E., Yu, W., Sood, A., Yang, J., Parmigiani, G., Matsui, W. H., & Berman, D. M. (2009) · Stem Cells · doi:10.1002/stem.92 · Cited by 138
Wong, Y., Litwin, S., Vaughn, D. J., Cohen, S., Plimack, E. R., Lee, J. D., Song, W., Dabrow, M. B., Brody, M. B., Tuttle, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.9572 · Cited by 129
New Therapeutic Challenges in Advanced Bladder Cancer
Joaquim Bellmunt, B., & Petrylak, D. P. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.08.007 · Cited by 127
An EGFR-ERK-SOX9 Signaling Cascade Links Urothelial Development and Regeneration to Cancer
Ling, S., Chang, X., Schultz, L., Lee, T. K. M., Chaux, A., Marchionni, L., Netto, G. J., Sidransky, D., & Berman, D. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3072 · Cited by 121
Pruthi, R. S., Nielsen, M. E., Heathcote, S. A., Wallen, E., Rathmell, W. K., Godley, P. A., Whang, Y. E., Fielding, J. R., Schultz, H., Grigson, G., et al. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.09101.x · Cited by 118
Varley, C. L., Hill, G., Pellegrin, S., Shaw, N. J., Selby, P. J., Trejdosiewicz, L. K., & Southgate, J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.02.004 · Cited by 93
Self-citationA Four-Gene Signature Predicts Disease Progression in Muscle Invasive Bladder Cancer
Kim, W., Kim, S., Jeong, P., Yun, S. J., Cho, I., Kim, I. Y., Moon, S.-K., Um, H., & Choi, Y. H. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00274 · Cited by 72
Marjou, A. E. (2000) · Carcinogenesis · doi:10.1093/carcin/21.12.2211 · Cited by 61
Cited by
Kamat, A. M., Hahn, N. M., Efstathiou, J. A., Lerner, S. P., Malmström, P.-U., Choi, W., Guo, C. C., Lotan, Y., & Kassouf, W. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30512-8 · Cited by 1,421
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
Kamoun, A., de Reyniès, A., Allory, Y., Sjödahl, G., Robertson, A. G., Seiler, R., Hoadley, K. A., Groeneveld, C. S., Al-Ahmadie, H., Choi, W., et al. (2020) · European Urology · doi:10.1016/j.eururo.2019.09.006 · Cited by 1,359
Self-citationMolecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Knowles, M. A., & Hurst, C. D. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3817 · Cited by 1,247
Sanli, O., Dobruch, J., Knowles, M. A., Burger, M., Alemozaffar, M., Nielsen, M. E., & Lotan, Y. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.22 · Cited by 814
Advances in bladder cancer biology and therapy
Tran, L., Xiao, J.-F., Agarwal, N., Duex, J. E., & Theodorescu, D. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00313-1 · Cited by 735
Metadata
- Authors
- Rebouissou, S., Bernard-Pierrot, I., de Reyniès, A., Lepage, M.-L., Krucker, C., Chapeaublanc, E., Hérault, A., Kamoun, A., Caillault, A., Letouzé, E., Elarouci, N., Neuzillet, Y., Denoux, Y., Molinié, V., Vordos, D., Laplanche, A., Maillé, P., Soyeux, P., Ofualuka, K., Reyal, F., Biton, A., Sibony, M., Paoletti, X., Southgate, J., Benhamou, S., Lebret, T., Allory, Y., & Radvanyi, F.
- Venue
- Science Translational Medicine
- Published
- 2014-07-09
- Volume
- 6
- Issue
- 244
- Pages
- 244ra91-244ra91
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2163941629
- Cited by
- 386
- References
- 36
- FWCI
- 25.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.